Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1

  • Cell Commun Signal. 2024 Jul 26;22(1):378. doi: 10.1186/s12964-024-01759-8.
Wuyi Liu  #  1 Huyue Zhou  #  1 Wenjing Lai  1 Changpeng Hu  1 Qiaoling Wang  1 Chengsha Yuan  1 Chunmei Luo  1 Mengmeng Yang  1 Min Hu  1 Rong Zhang  2 Guobing Li  3
Affiliations
  • 1. Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
  • 2. Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China. [email protected].
  • 3. Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China. [email protected].
  • # Contributed equally.
Abstract

Artesunate (ART), a natural product isolated from traditional Chinese plant Artemisia annua, has not been extensively explored for its anti-melanoma properties. In our study, we found that ART inhibited melanoma cell proliferation and induced melanoma cell Ferroptosis. Mechanistic study revealed that ART directly targets IDO1, thereby suppressing Hic1-mediated transcription suppression of Hmox1, resulting in melanoma cell Ferroptosis. In CD8+ T cells, ART does not cause cell Ferroptosis due to the low expression of Hmox1. It also targets IDO1, elevating tryptophan levels, which inhibits NFATc1-mediated PD1 transcription, consequently activating CD8+ T cells. Our study uncovered a potent and synergistic anti-melanoma efficacy arising from ART-induced melanoma cell Ferroptosis and concurrently enhancing CD8+ T cell-mediated immune response both in vivo and in vitro through directly targeting IDO1. Our study provides a novel mechanistic basis for the utilization of ART as an IDO1 Inhibitor and application in clinical melanoma treatment.

Keywords
Artesunate; CD8+ T cell; Ferroptosis; Ido1; Melanoma.
Products